Since MMR deficiency plays a key role in intestinal tumorigenesis as above detailed, we wanted to explore the role of NRIP1 in this subgroup of CRC and investigate its implication in the control of MMR gene expression by combining the use of human CRC cell lines and genetically modified mouse models. This evidence concerns the gene MRC1 and colorectal carcinoma.